Skip to Main Content
TABLE 1

Plasma glucose, insulin, NEFA, and triglyceride concentrations after an overnight fast and at the end of the 80 mU · m–2 · min–1 hyperinsulinemic-euglycemic clamps in 8 normal women and 10 normal men in the absence and presence of an infusion of Intralipid and heparin

Women (n = 8)
Men (n = 10)
ControlLipidControlLipid
Plasma glucose (mmol/l) 
 Fasting 4.9 ± 0.2 4.8 ± 0.1 4.9 ± 0.1 5.0 ± 0.1 
 End of clamp 4.8 ± 0.1 4.9 ± 0.1 5.0 ± 0.0 5.1 ± 0.0 
Plasma insulin (mU/l) 
 Fasting 8.9 ± 1.5 9.6 ± 2.0 7.0 ± 1.7 7.8 ± 1.6 
 End of clamp 123 ± 9 128 ± 18 118 ± 7 117 ± 8 
Plasma NEFA (μmol/l) 
 Fasting 535 ± 81 1,148 ± 75* 351 ± 51 1,018 ± 60* 
 End of clamp 24 ± 5 809 ± 105* 15 ± 4 780 ± 80* 
Plasma triglyceride (mg/dl) 
 Fasting 145 ± 41 321 ± 70 104 ± 21 223 ± 36* 
 End of clamp 97 ± 36 317 ± 80 71 ± 20 277 ± 51* 
Women (n = 8)
Men (n = 10)
ControlLipidControlLipid
Plasma glucose (mmol/l) 
 Fasting 4.9 ± 0.2 4.8 ± 0.1 4.9 ± 0.1 5.0 ± 0.1 
 End of clamp 4.8 ± 0.1 4.9 ± 0.1 5.0 ± 0.0 5.1 ± 0.0 
Plasma insulin (mU/l) 
 Fasting 8.9 ± 1.5 9.6 ± 2.0 7.0 ± 1.7 7.8 ± 1.6 
 End of clamp 123 ± 9 128 ± 18 118 ± 7 117 ± 8 
Plasma NEFA (μmol/l) 
 Fasting 535 ± 81 1,148 ± 75* 351 ± 51 1,018 ± 60* 
 End of clamp 24 ± 5 809 ± 105* 15 ± 4 780 ± 80* 
Plasma triglyceride (mg/dl) 
 Fasting 145 ± 41 321 ± 70 104 ± 21 223 ± 36* 
 End of clamp 97 ± 36 317 ± 80 71 ± 20 277 ± 51* 

Data are means ± SE.

*

P < 0.001,

P < 0.01,

P < 0.005 compared with the control study.

Close Modal

or Create an Account

Close Modal
Close Modal